Although the clinical data component for model development was simpler than our study (serum CEA, T stage, and pathologic tumor grade), they also used solely T2WI for radiomics analysis and demonstrated enhanced model performance for combined clinical and radiomics data as well. The gene discussed is CEACAM5; the disease is neoplasm.